YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine (Q45032979)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

chronic hepatitis B

1 reference

based on heuristic

inferred from title

Hiromitsu Kumada

15

object named as

Hiromitsu Kumada

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Fumitaka Suzuki

2

object named as

Fumitaka Suzuki

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

13

object named as

Kenji Ikeda

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Masahiro Kobayashi

8

object named as

Masahiro Kobayashi

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Yoshiyuki Suzuki

3

object named as

Yoshiyuki Suzuki

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

5

object named as

Norio Akuta

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

10

object named as

Yasuji Arase

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

9

object named as

Satoshi Saitoh

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Mariko Kobayashi

12

object named as

Mariko Kobayashi

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

7

object named as

Takashi Someya

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

author name string

Marie Matsuda

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Akihito Tsubota

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Tetsuya Hosaka

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Junko Satoh

11

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Yuzo Miyakawa

14

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

publication date

1 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

74

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

361-366

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

(-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20185

21 January 2018

Identifiers

10.1002/JMV.20185

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45032979&oldid=2063482270"